로딩 중…
지수 로딩 중…
Keros Therapeutics, Inc.
KROS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$10.65+2.31%
2026-06-18
Price Chart
Keros Therapeutics, Inc.-21.40%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $211M |
| Revenue | $33M |
| Net Income | $-85M |
| Total Assets | $312M |
| Net Assets | $286M |
| Value | |
| P/B | 0.74x |
| P/S | 6.35x |
| FCF Yield | -27.64% |
| Profitability | |
| ROE | -29.81% |
| ROA | -27.26% |
| Op. Margin | -332.55% |
| Revenue Growth | -99.83% |
| Earnings Growth | -115.97% |
| Financial Health | |
| Debt Ratio | 9.33% |
| Total Debt | $16M |
| FCF | $-58M |
| Cash | $281M |
| Current Ratio | 22.62x |
| Performance | |
| 1Y Return | -21.40% |
| 1M Return | 7.47% |
| From 52W High | -52.77% |
| 1Y MDD | -54.62% |
| Trading | |
| Volume | 395,789 shares |
| Trading Value | $4M |
| Per Share | |
| EPS | $2.34 |
| BPS | $8.14 |